Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 40 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A042917017 | - | - | - | - | 1件: 21 21 💬1. A042917017
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬2. Acetylcysteine
| - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬2. Acetylcysteine
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Alpha-tocotrienol quinone | 1件: Tocotrienol Tocotrienol | - | - | - | 2件: 21 21, 156 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Bupropion | 1件: Bupropion Bupropion | 1件: Bupropion
Bupropion
💬4. Bupropion
| 2件: SLC6A2 SLC6A2,SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, P ... | 5件: 8 8, 18, 21, 96, 171 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Caffeine | 1件: Caffeine Caffeine | 2件: Caffeine
Caffeine
,Caffeine hydrate 💬 5. Caffeine
| 11件: ADORA1 ADORA1,ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 5. Caffeine | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pa ... | 8件: 2 2, 6, 21, 46, 78, 96, 97, 265 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | CoenzymeQ10 | - | - | - | - | 1件: 21 21 💬6. CoenzymeQ10
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Cysteamine | 1件: Cysteamine Cysteamine | 1件: Cysteamine
Cysteamine
💬7. Cysteamine
| - | - | 4件: 8 8, 19, 21, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Cysteamine Bitartrate | 1件: Cysteamine Cysteamine | 1件: Cysteamine
Cysteamine
💬8. Cysteamine Bitartrate
| - | - | 4件: 8 8, 19, 21, 299 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 1件: Dexmedetomidine
Dexmedetomidine
💬9. DEXMEDETOMIDINE
| 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬9. DEXMEDETOMIDINE
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 1件: Dextromethorphan
Dextromethorphan
💬10. Dextromethorphan
| 6件: GRIN1 GRIN1,GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 10. Dextromethorphan
| 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬10. Dextromethorphan
|